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ABSTRACT
Purpose: The tumor microenvironment is known to be associated with the metabolic activity 
of cancer cells and local immune reactions. We hypothesized that glucose metabolism 
measured by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography 
(PET)-computed tomography (CT) (18F-FDG PET-CT) would be associated with local immune 
responses evaluated according to the presence of tumor infiltrating lymphocytes (TILs).
Materials and Methods: We retrospectively reviewed 56 patients who underwent 18F-FDG 
PET-CT prior to gastrectomy. In resected tumor specimens, TIL subsets, including cluster of 
differentiation (CD) 3, CD4, CD8, Forkhead box P3 (Foxp3), and granzyme B, were subjected 
to immunohistochemical analysis. The prognostic nutritional index (PNI) was calculated 
as: (10×serum albumin value)+(0.005×peripheral lymphocyte counts). Additionally, the 
maximum standard uptake value (SUVmax) was calculated to evaluate the metabolic activity of 
cancer cells.
Results: The SUVmax was positively correlated with larger tumor size (R=0.293; P=0.029) and 
negatively correlated with PNI (R=−0.407; P=0.002). A higher SUVmax showed a marginal 
association with higher CD3 (+) T lymphocyte counts (R=0.227; P=0.092) and a significant 
association with higher Foxp3 (+) T lymphocyte counts (R=0.431; P=0.009). No other 
clinicopathological characteristics were associated with SUVmax or TILs. Survival analysis, 
however, indicated that neither SUVmax nor Foxp3 held prognostic significance.
Conclusions: FDG uptake on PET-CT could be associated with TILs, especially regulatory 
T cells, in gastric cancer. This finding may suggest that PET-CT could be of use as a non-
invasive tool for monitoring the tumor microenvironment in patients with gastric cancer.
Keywords: Fluorodeoxyglucose F18; PET-CT; Tumor infiltrating lymphocytes;  
Regulatory T-cells; Tumor microenvironment
INTRODUCTION
Gastric cancer is the fourth most common cancer worldwide, and the third leading cause 
of cancer-related death [1]. Despite improvements in diagnostic methods and therapeutic 
strategies, the prognosis of gastric cancer is still determined by cancer stage alone [2]. 
However, accurate tumor staging can only be achieved after surgical resection.
J Gastric Cancer. 2017 Dec;17(4):384-393
https://doi.org/10.5230/jgc.2017.17.e43
pISSN 2093-582X·eISSN 2093-5641
Original Article
Received: Dec 19, 2017
Revised: Dec 22, 2017
Accepted: Dec 22, 2017
Correspondence to
Hyoung-Il Kim
Department of Surgery, Yonsei University 
College of Medicine, Yonsei University Health 
System, 50-1 Yonsei-ro, Seodaemun-gu,  
Seoul 03722, Korea.
E-mail: cairus@yuhs.ac
Copyright © 2017. Korean Gastric Cancer 
Association
This is an Open Access article distributed 
under the terms of the Creative Commons 
Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0) 
which permits unrestricted noncommercial 
use, distribution, and reproduction in any 
medium, provided the original work is properly 
cited.
ORCID iDs
Seungho Lee 
https://orcid.org/0000-0001-6958-7581
Seohee Choi 
https://orcid.org/0000-0002-9384-8646
Sang Yong Kim 
https://orcid.org/0000-0001-6066-849X
Hyoung-Il Kim 
https://orcid.org/0000-0002-6134-4523
Funding
This work was supported by the National 
Research Foundation of Korea (NRF) grant 
funded by the Korean government (MSIP) (No. 
2016R1A2B4014984).
Seungho Lee  1, Seohee Choi  1, Sang Yong Kim  2,3, Mi Jin Yun4,  
Hyoung-Il Kim  1,2,3
1Department of Surgery, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea
2Medical Research Center, Yonsei University College of Medicine, Seoul, Korea
3 Open NBI Convergence Technology Research Laboratory, Severance Hospital, Yonsei University Health 
System, Seoul, Korea
4Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Korea
Potential Utility of FDG PET-CT as a 
Non-invasive Tool for Monitoring Local 
Immune Responses
Author Contributions
Conceptualization: Y.M.J., K.H.I.; Data 
curation: L.S., C.S., K.S.Y.; Formal analysis: 
L.S., K.H.I.; Funding acquisition: K.H.I.; 
Investigation: Y.M.J., K.H.I.; Methodology: 
L.S., C.S., K.S.Y.; Project administration: K.H.I.; 
Supervision: Y.M.J., K.H.I.; Writing - original 
draft: L.S.; Writing - review & editing: K.H.I.
Conflict of Interest
No potential conflict of interest relevant to this 
article was reported.
To predict prognosis in patients with cancer, 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG)-positron 
emission tomography (PET)-computed tomography (CT) (18F-FDG PET-CT) has been widely used 
[3-5]. In PET-CT analysis, increased cell metabolic activity is reflected by increased FDG uptake. 
This mechanism of action allows PET-CT to be used in diagnosing cancer severity [3,6] and in 
predicting response to preoperative chemotherapy [7]. In this respect, the metabolic activity of 
cancers can be considered an important factor affecting tumor biology and patient prognosis. 
In gastric cancer, however, the sensitivity and specificity of 18F-FDG PET-CT have been found to 
vary according to histologic type [8], limiting the role of this modality in the detection of primary 
tumors [9]. Notwithstanding, several studies have reported that increased FDG uptake by primary 
tumors and metastatic lymph nodes is associated with poor prognosis in gastric cancer [10-12].
Recently, the tumor microenvironment has emerged as another aspect important in the 
further understanding of tumor biology [13]. In particular, the tumor microenvironment 
has been found to play an essential role in the metabolic activity of cancers [14]. In this 
respect, the potential utility of 18F-FDG PET-CT as an indirect tool for monitoring the tumor 
microenvironment has been suggested [14-17]. Additional factors associated with the tumor 
microenvironment are tumor infiltrating lymphocytes (TILs) [18-20]. TILs are considered 
prognostic factors in local anti-tumor immunity and oncologic outcomes [21-24]. Indeed, 
in gastric cancer, several studies have reported a relationship between subsets of TILs and 
oncologic outcomes [22,25,26]. Interestingly, regulation of TIL subsets and the function of T 
cells have been shown to be influenced by the tumor microenvironment [18,19,27,28].
We hypothesized that the tumor microenvironment would be associated with the metabolic 
activity of cancer cells and would contribute to local immune responses in gastric cancer. 
Accordingly, we explored associations between FDG uptake on PET-CT and TILs in patients 
with gastric cancer.
MATERIALS AND METHODS
Patients
The present study included 56 patients with gastric cancer who underwent surgical resection 
and 18F-FDG PET-CT for staging workup at Severance Hospital, Yonsei University College of 
Medicine between June 2005 and December 2010. The medical records of these patients were 
retrospectively reviewed, and clinicopathological data were collected, including age, sex, 
tumor size, histologic type, pathologic T classification, and N classification. Tumor staging 
and pathologic grading were based on the American Joint Committee on Cancer (AJCC), 
seventh edition [29]. We obtained PET-CT workup and laboratory data, including serum 
albumin levels and lymphocyte counts, from baseline workup conducted within 2 months 
prior to surgery. The prognostic nutritional index (PNI) was calculated as follows [30]:
PNI=(10×serum albumin value [g/dL])+(0.005×peripheral lymphocyte count [number/mm3])
This study was approved by the Institutional Review Board of Severance Hospital, Yonsei 
University Health System (4-2017-0824).
18F-FDG PET-CT imaging
18F-FDG PET-CT scans were performed with a PET-CT scanner (Discovery STe; GE Healthcare, 
Little Chalfont, UK; or Biograph TruePoint 40; Siemens Healthcare, Erlangen, Germany). All 
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patients fasted for at least 6 hours before undergoing PET-CT scan, and a dose of 5.5 MBq/
kg of 18F-FDG was intravenously injected 60 minutes prior to PET-CT. CT scans were initially 
performed at 30 mA and 130 kVp without contrast enhancement. After the CT scan was 
complete, a PET scan was performed with an acquisition time of 3 minutes per bed position 
in 3-dimensional mode. PET images were reconstructed using ordered subset expectation 
maximization with an attenuation correction. 18F-FDG PET-CT images were reviewed by 
nuclear medicine physicians (Fig. 1A). The maximum standard uptake value (SUVmax) on PET 
images was measured using volume viewer software (MIM-6.4; MIM software Inc., Cleveland, 
OH, USA). Each tumor was examined with a spherical-shaped volume of interest (VOI) that 
included the entire lesion in the axial, sagittal, and coronal planes. Using CT images, 18F-FDG 
uptake of normal organs, such as the brain, heart, liver, kidney, and small bowel was not 
included in the VOI. The SUVmax of the VOI was calculated as:
SUVmax of the VOI=(decay corrected activity/tissue volume)/(injected dose/body weight)
Immunohistochemistry of TILs
Immunohistochemical staining was performed on formalin-fixed, paraffin-embedded gastric 
cancer tissue sections. We used primary monoclonal antibodies for TIL subsets, including 
cluster of differentiation (CD) 3 (T lymphocytes, 1:100; Lab Vision Corp., Fremont, CA, 
USA; Fig. 1B), CD4 (helper T lymphocytes, 1:100; Novocastra Laboratories Ltd., Newcastle 
Upon Tyne, UK; Fig. 1C), CD8 (cytotoxic T lymphocytes, 1:100 Novocastra Laboratories 
Ltd.; Fig. 1D), Forkhead box P3 (Foxp3) (regulatory T lymphocytes, 1:100, ab20034; Abcam, 
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Fig. 1. Representative images of 18F-FDG PET-CT and immunohistochemical staining for TILs. (A) Whole-body 18F-FDG PET image demonstrates increased FDG 
uptake in stomach. (B, C) Axial CT and fused images indicate primary gastric cancer. (D-H) Immunohistochemical analysis of TILs, including CD3, CD4, CD8, 
Foxp3, and granzyme B. 
18F-FDG = 2-deoxy-2-(18F)fluoro-D-glucose; PET = positron emitting tomography; CT = computed tomography; TIL = tumor infiltrating lymphocyte; CD = cluster of 
differentiation; Foxp3 = Forkhead box P3.
Cambridge, UK; Fig. 1E), and granzyme B (activated cytotoxic T lymphocytes, 1:100; Lab 
Vision Corp.; Fig. 1F). Stained slides were reviewed by an experienced pathologist who was 
blinded to patient data. Precise immunohistochemical staining methods and quantification 
of TILs were described in our previous study [22].
Statistical analysis
Categorical data are expressed as numbers with percentages, and continuous variables are 
expressed as means±standard deviations. Continuous variables were analyzed with analysis of 
variance (ANOVA). Correlation analyses were performed with Spearman's correlation analysis 
test. P-values less than 0.05 were considered statistically significant. Overall survival (OS) 
was compared with Kaplan-Meier analysis and the log-rank test. All statistical analyses were 
performed with SPSS software, version 23 (IBM Corporation, Chicago, IL, USA).
RESULTS
Patients
Clinicopathologic characteristics of the patients are shown in Table 1. Fifty-six patients with 
gastric cancer who underwent radical resection were included, including 36 men and 20 
women. The mean tumor size was 57.6 mm. The majority of patients had poorly differentiated 
cancer (44.6%), T3 (30.4%), and T4 (32.1%) tumors, N0 tumors (33.9%), and stage III (37.5%) 
tumors. The mean SUVmax was 7.59, and the mean numbers of patients with CD3, CD4, CD8, 
Foxp3, and granzyme B TILs were 173.1, 104.2, 84.4, 18.0, and 19.9, respectively.
SUVmax on PET-CT and associated characteristics
In correlation analysis of clinicopathological characteristics, SUVmax was not associated with age, 
sex, histologic subtype, N classification, or final stage. A high SUVmax value was associated with 
larger tumor size (Fig. 2A, R=0.293; P=0.029) and advanced T classification (Fig. 2B, P=0.039), 
and showed a negative correlation with PNI (Fig. 2C, R=−0.407; P=0.002). In correlation analysis 
of TILs (Fig. 2D-H), SUVmax showed a marginal association with CD3 (+) lymphocytes (Fig. 2D, 
R=0.227; P<0.092) and a significant association with Foxp3 (+) regulatory T cell counts (Fig. 2G, 
R=0.431; P<0.001). CD4, CD8, and granzyme B were not associated with SUVmax.
Foxp3 (+)TILs and associated characteristics
Because only Foxp3 was correlated with SUVmax, we performed further investigation of Foxp3 and 
clinicopathological characteristics. Although Foxp3 and SUVmax were significantly correlated, 
Foxp3 counts showed poor correlation with clinicopathological characteristics, as shown in  
Fig. 3. Notably, however, Foxp3 counts were highest in patients with T3 disease and lowest in 
those with T4 disease (Fig. 3C, mean Foxp3 count=23.27 and 14.65, respectively, P=0.033).
Survival analysis
No OS differences were found between the groups with high and low SUVmax (Fig. 4A) or 
between the high and low Foxp3 (+) T cell groups (Fig. 4B).
DISCUSSION
In this study, we used SUVmax on 18F-FDG PET-CT to evaluate the metabolic activity of gastric 
cancer tumors and TIL subsets as a reflection of local immune responses. SUVmax showed positive 
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correlations with tumor size and regulatory T lymphocytes, and a negative correlation with PNI. We 
noted no prognostic significance for SUVmax and regulatory T lymphocytes in the present study.
Standard uptake value is the ratio between 18F-FDG concentrations in a tumor and those 
throughout the entire body, and SUVmax is the maximum concentration of 18F-FDG in an organ 
of interest. High SUVmax generally indicates increased cancer metabolism, and has been 
shown to be associated with aggressive behavior, advanced disease status, and poor oncologic 
outcomes [5,11,31,32]. In the present study, we identified associations among tumor size, 
SUVmax, and regulatory T lymphocytes. The observed association between large tumor size 
and high SUVmax corroborates the findings of a previous report on gastric cancer [16]. To 
the best of our knowledge, however, we are the first to report a strong association between 
SUVmax and TILs: this relationship had never previously been explored in gastric cancer, and 
has rarely been studied in other solid cancers [33].
Hypothetically, increased glucose uptake in cancerous tissue would likely be associated 
with changes in the tumor microenvironment, reflecting tumor proliferation and increased 
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Table 1. Patient characteristics
Characteristics Value
Age (yr) 59.3±12.5
Sex
Male 36 (64.3)
Female 20 (35.7)
Tumor size (mm) 57.6±31.7
Histologic subtype
AWD 8 (14.3)
AMD 14 (25.0)
APD 25 (44.6)
Other* 9 (16.1)
Pathologic T classification
T1 13 (23.2)
T2 8 (14.3)
T3 17 (30.4)
T4 18 (32.1)
Pathologic N classification
N0 19 (33.9)
N1 13 (23.2)
N2 9 (16.1)
N3 15 (26.8)
TNM stage
I 13 (23.2)
II 17 (30.4)
III 21 (37.5)
IV 5 (8.9)
PNI 51.4±6.9
SUVmax 7.6±6.7
TIL subset
CD3 173.1±52.0
CD4 104.2±59.5
CD8 84.4±28.5
Foxp3 18.0±9.5
Granzyme B 19.9±19.1
Foxp3/CD4 (%) 21.9±16.6
Data are shown as mean±standard deviation or number (%).
AWD = well-differentiated; AMD = moderately differentiated; APD = poorly differentiated; TNM = tumor, node, and 
metastasis; PNI = prognostic nutritional index; SUVmax = maximum standard uptake value; TIL = tumor infiltrating 
lymphocyte; CD = cluster of differentiation; Foxp3 = Forkhead box P3.
*Mucinous-1, signet-ring cell cancer-1, and undifferentiated-7.
glucose metabolism [34,35]. These changes are also known to influence regulation of TIL 
subsets and the function of T cells [18,19,27,28]. Among the many factors in the tumor 
microenvironment that modulate the differentiation and function of TILs [36-39], the most 
relevant connection between SUVmax and Foxp3 could be hypoxia and acidic conditions. 
Regarding the former, FDG uptake is upregulated in hypoxic conditions [17,40,41], and it 
is well-known that hypoxia modulates immune responses in the tumor microenvironment 
[36,42] and promotes proliferation of regulatory T cells [18,43]. In relation to the latter, 
high lactate concentrations in the tumor microenvironment have been found to block 
lactate export in T cells, thereby perturbing the metabolism and function of these cells 
[27]. Although our study did not explore the mechanism linking high FDG uptake and high 
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Fig. 2. SUVmax on PET-CT and associated characteristics. (A) Correlation analysis of SUVmax and tumor size. (B) SUVmax in comparison to T classification. (C-H) 
Correlation analysis of SUVmax and TIL subsets, including CD3, CD4, CD8, Foxp3, and granzyme B. Significant correlation shown only between Foxp3 and SUVmax 
(R=0.431, P<0.001). 
SUVmax = maximum standard uptake value; PET = positron emitting tomography; CT = computed tomography; TIL = tumor infiltrating lymphocyte; CD = cluster of 
differentiation; Foxp3 = Forkhead box P3. 
*P<0.05.
regulatory T lymphocyte infiltration, our results suggest that 18F-FDG PET-CT could be of use 
as a potential diagnostic modality for assessing the tumor-immune microenvironment and as 
a predictive tool for identifying patients who might benefit from regulatory T cell depleting 
immunotherapy.
390https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e43
FDG Uptake in PET-CT and TILs
R=0.115
P=0.399
R=−0.092
P=0.499
AWD AMD APD
B
Fo
xp
3
30
40
20
10
0
A
Fo
xp
3 30
50
40
20
10
50 100 150 200
Size (mm)
0
20 40 60 80
PNI
D
Fo
xp
3 30
40
50
20
10
0
C
Fo
xp
3
30
40
20
10
T1 T2 T3 T4
*
0
Fig. 3. Foxp3 (+) TILs and associated characteristics. (A) Correlation analysis of tumor size and Foxp3.  
(B, C) Comparison of Foxp3 according to histologic grade of gastric cancer and T classification. No significant 
associations among histologic grade and T classification were noted, except between T3 and T4. (D) Correlation 
analysis of PNI and Foxp3. 
Foxp3 = Forkhead box P3; TIL = tumor infiltrating lymphocyte; PNI = prognostic nutritional index; AWD = well-
differentiated; AMD = moderately differentiated; APD = poorly differentiated. 
*P<0.05.
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Fig. 4. Kaplan-Meier analysis according to SUVmax and Foxp3 positivity. (A) OS for the high SUVmax and low SUVmax groups. A median OS of 89 months was recorded 
in the low SUVmax group. However, a median OS was not defined in the high SUVmax group (P=0.425). (B) OS between high Foxp3 and low Foxp3 groups. The median 
OS in the low Foxp3 group was 89 months, while the median OS in the high Foxp3 group was undefined (P=0.767). The differences between the groups were 
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SUVmax = maximum standard uptake value; Foxp3 = Forkhead box P3; OS = overall survival.
The present study has several limitations. First, this was a retrospective observational study 
of a small number of cases. As a potential result thereof, our study identified no survival 
differences between the groups with high and low SUVmax and between the high and low Foxp3 
(+) T cell groups, despite the fact that SUVmax and Foxp3 are well-known prognostic factors 
in gastric cancer [11,22]. Second, the biologic mechanisms underlying associations between 
higher numbers of regulatory TILs and high FDG uptake were not assessed. Nonetheless, 
the strength of the present study is that it is the first to evaluate associations among 18F-FDG 
uptake on PET-CT, clinicopathological characteristics, and TILs in gastric cancer.
In conclusion, the present study highlights a novel association between SUVmax on 18F-FDG 
PET-CT and regulatory T cells in gastric cancer, suggesting that the metabolic activity of 
gastric cancer cells could be related to local immune responses. Accordingly, this study 
provides the rationale for further studies of the role of 18F-FDG PET-CT as a non-invasive tool 
for monitoring cancer metabolism and immune responses in the tumor microenvironment of 
gastric and other cancers.
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